Related Experiment Video
Updated: Jun 15, 2026
20:16
Detecting Anastasis In Vivo by CaspaseTracker Biosensor
Published on: February 1, 2018
On the death Trk
Liraz Harel1, Barbara Costa, Mike Fainzilber
1Department of Biological Chemistry, Weizmann Institute of Science, 76100 Rehovot, Israel.
Developmental Neurobiology
|February 27, 2010
Summary
Receptor tyrosine kinases (RTKs) in the Trk family paradoxically promote neuronal survival and induce cell death in pediatric tumors. New research reveals TrkA interaction with CCM2 protein may mediate this cell death, offering prognostic insights.
Area of Science:
- Neuroscience
- Oncology
- Molecular Biology
Background:
- The Trk family of receptor tyrosine kinases (RTKs) is crucial for nervous system development, supporting neuronal survival and differentiation.
- Paradoxically, Trk family members can also induce cell death in pediatric tumor cells of neuronal origin, such as neuroblastoma and medulloblastoma.
- TrkA and TrkC are established as favorable prognostic indicators in neuroblastoma and medulloblastoma, respectively, suggesting a complex role in these cancers.
Purpose of the Study:
- To investigate the mechanisms underlying the paradoxical induction of cell death by Trk family members in neuronal tumor cells.
- To explore the potential link between TrkA signaling and cell death pathways, including p75-dependent and independent mechanisms.
- To elucidate the role of the novel TrkA-CCM2 interaction in Trk-mediated cell death and its clinical relevance in neuroblastoma.
Main Methods:
- Review of recent findings on TrkA signaling pathways involved in neuronal cell death.
- Analysis of the interaction between TrkA and CCM2 (cerebral cavernous malformation 2) protein.
- Examination of cell death induction in medulloblastoma and neuroblastoma cell lines upon coexpression of CCM2 and TrkA.
- Correlation analysis of CCM2 expression levels with TrkA expression and patient prognosis in neuroblastoma.
Main Results:
- Recent studies suggest TrkA may induce neuronal cell death via stimulation of p75 cleavage.
- A novel, p75-independent mechanism involving TrkA interaction with CCM2 has been identified.
- Coexpression of CCM2 with TrkA triggers cell death in medulloblastoma and neuroblastoma cells.
- CCM2 expression levels positively correlate with TrkA levels and favorable prognosis in neuroblastoma patients.
Conclusions:
- Emerging evidence points to TrkA-CCM2 interaction as a key mechanism in Trk-induced neuronal cell death.
- This interaction provides mechanistic insights into the dual role of Trk signaling in neuronal development and cancer.
- Further research into these mechanisms and their in vivo significance is warranted for potential therapeutic applications in neuroblastoma and medulloblastoma.
Related Concept Videos
01:21Kubler Ross's Stages of Dying
Elisabeth Kübler-Ross significantly advanced psychology's understanding of the process of dying with her influential book, On Death and Dying (1969). She focused on studying terminally ill individuals and outlined five stages commonly experienced when coping with death: denial, anger, bargaining, depression, and acceptance.
In denial, individuals reject the reality of their condition, often thinking, "This isn't true; I feel fine," as a way to protect themselves from emotional distress. Anger...
In denial, individuals reject the reality of their condition, often thinking, "This isn't true; I feel fine," as a way to protect themselves from emotional distress. Anger...
01:30Overview of Cell Death
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
01:18Autophagic Cell Death
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
01:30Apoptosis
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
01:09Truncation in Survival Analysis
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are observed.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are observed.